Predicting clinical response in people at ultra-high risk of psychosis: a systematic and quantitative review

Drug Discovery Today
A MechelliShitij Kapur

Abstract

People at ultra-high risk (UHR) of psychosis have ∼30% chance of developing the illness within two years. A range of pharmacological and psychosocial interventions are now available but there is great individual variation in clinical response. Here we examine the evidence for clinically applicable predictors of clinical response in people at UHR of psychosis. We report that currently there are no reliable predictive markers that can be used to optimise treatment. We argue that there is an urgent need for a better understanding of why some people at UHR of psychosis benefit from a certain treatment whereas others do not. This information will help clinicians make more-effective treatment decisions, and improve long-term clinical outcomes in this population.

References

Jun 30, 1988·The New England Journal of Medicine·A LaupacisR S Roberts
Oct 9, 2002·Archives of General Psychiatry·Helena Chmura KraemerW Stewart Agras
Oct 2, 2004·The British Journal of Psychiatry : the Journal of Mental Science·Anthony P MorrisonRichard P Bentall
Jan 19, 2008·The British Journal of Psychiatry. Supplement·S RuhrmannUNKNOWN LIPS study group
Oct 7, 2008·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Patrick D McGorryAlison Yung
Aug 12, 2009·The Australian and New Zealand Journal of Psychiatry·Lisa J PhillipsPatrick D McGorry
Jun 29, 2011·Molecular Psychiatry·R H Perlis
Nov 21, 2012·JAMA Psychiatry·Paolo Fusar-PoliAlison Yung
Dec 12, 2012·Frontiers in Psychiatry·Wi Hoon JungJun Soo Kwon
Jan 22, 2013·BMJ : British Medical Journal·Megan R StaffordTim Kendall
Jun 1, 2014·Neuroscience and Biobehavioral Reviews·Diana PrataShitij Kapur

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here